genprowebdirectory
Skip to content
Facebook
LinkedIn
RSS
Twitter/X
YouTube
GEN Edge
Featured News
Multimedia
Content
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
A-Lists
eBooks/Perspectives
Tutorials
New Products
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Toggle Search
Search for:
Search
Search
Toggle Mobile Menu
Toggle Search
×
GEN Edge
Expand submenu
Featured News
Multimedia
Content
Expand submenu
News
Insights
Topics
Expand submenu
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Expand submenu
Browse Issues
Subscribe
Multimedia
Expand submenu
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
Expand submenu
A-Lists
eBooks/Perspectives
Tutorials
New Products
Subscribe
Expand submenu
Get GEN Magazine
Get GEN eNewsletters
×
Search for:
Search
Search
Home
Authors
Posts by Kevin Davies, PhD
Kevin Davies, PhD
Genome Editing
The News from New Orleans:
GEN
‘s Takeaways from ASGCT
Genome Editing
Biotech and Beignets: The News from Day One of ASGCT
Drug Discovery
Industry Voices Alarm as Peter Marks Departs FDA
Genome Editing
Experts Discuss Guardrails for Heritable Human Genome Editing
Genome Editing
Genetic Engineering at Asilomar, Stand Up for Science, and Francis Collins
OMICs
Former NIH Director Francis Collins Praises the Institution as He Abruptly Departs After Three Decades
OMICs
The Sun Sets on AGBT 2025: Final Report from Marco Island
OMICs
AGBT 2025: A Video Update from Day Two
OMICs
Sun, Sequencing, and Spatial: Day One at AGBT 2025
Translational Medicine
Running Up That Hill: An Interview with Carole Ho, Denali Therapeutics
Artificial Intelligence
Key Drivers of AI Drug Discovery
Genome Editing
Going Public: Doudna’s Dream Team Launches Groundbreaking Sickle Cell Trial
Genome Editing
Prime Medicine Spat with Tessera Rumbles on at ESGCT
Genome Editing
“Give Cas a Chance”: Fyodor Urnov Says He Wants a CRISPR Revolution
Bioprocessing
MilliporeSigma Opens Glitzy $286 Million Biosafety Testing Facility in Maryland
Genome Editing
Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies
Genome Editing
A Story of Perseverance: An Interview with Matthew Porteus
Genome Editing
ASGCT 2024: David Liu Touts Rapid Evolution of Gene-Sized Programmable Editing Technologies
Genome Editing
ASGCT 2024: A Video Update from Baltimore
Genome Editing
ASGCT 2024: Mammoth Sizes Up Genome Editing Opportunities
<
1
2
3
4
5
…
7
>
Page 3 of 7